Transmembrane Domains of Highly Pathogenic Viral Fusion Proteins Exhibit Trimeric Association \u3cem\u3eIn Vitro\u3c/em\u3e by Webb, Stacy R. et al.
University of Kentucky
UKnowledge
Molecular and Cellular Biochemistry Faculty
Publications Molecular and Cellular Biochemistry
4-18-2018
Transmembrane Domains of Highly Pathogenic
Viral Fusion Proteins Exhibit Trimeric Association
In Vitro
Stacy R. Webb
University of Kentucky, stacy.webb@uky.edu
Stacy E. Smith
University of Kentucky, ssmit7@uky.edu
Michael G. Fried
University of Kentucky, michael.fried@uky.edu
Rebecca Ellis Dutch
University of Kentucky, rebecca.dutch@uky.edu
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/biochem_facpub
Part of the Amino Acids, Peptides, and Proteins Commons, Biochemistry, Biophysics, and
Structural Biology Commons, Microbiology Commons, and the Viruses Commons
This Article is brought to you for free and open access by the Molecular and Cellular Biochemistry at UKnowledge. It has been accepted for inclusion in
Molecular and Cellular Biochemistry Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact
UKnowledge@lsv.uky.edu.
Repository Citation
Webb, Stacy R.; Smith, Stacy E.; Fried, Michael G.; and Dutch, Rebecca Ellis, "Transmembrane Domains of Highly Pathogenic Viral
Fusion Proteins Exhibit Trimeric Association In Vitro" (2018). Molecular and Cellular Biochemistry Faculty Publications. 138.
https://uknowledge.uky.edu/biochem_facpub/138
Transmembrane Domains of Highly Pathogenic Viral Fusion Proteins Exhibit Trimeric Association In Vitro
Notes/Citation Information
Published in mSphere, v. 3, issue 2, e00047-18, p. 1-6.
Copyright © 2018 Webb et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0
International license.
Digital Object Identifier (DOI)
https://doi.org/10.1128/mSphere.00047-18
This article is available at UKnowledge: https://uknowledge.uky.edu/biochem_facpub/138
Transmembrane Domains of Highly Pathogenic Viral Fusion
Proteins Exhibit Trimeric Association In Vitro
Stacy R. Webb,a Stacy E. Smith,a Michael G. Fried,a Rebecca Ellis Dutcha
aDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, USA
ABSTRACT Enveloped viruses require viral fusion proteins to promote fusion of the
viral envelope with a target cell membrane. To drive fusion, these proteins undergo
large conformational changes that must occur at the right place and at the right
time. Understanding the elements which control the stability of the prefusion state
and the initiation of conformational changes is key to understanding the function of
these important proteins. The construction of mutations in the fusion protein trans-
membrane domains (TMDs) or the replacement of these domains with lipid anchors
has implicated the TMD in the fusion process. However, the structural and molecu-
lar details of the role of the TMD in these fusion events remain unclear. Previously,
we demonstrated that isolated paramyxovirus fusion protein TMDs associate in a
monomer-trimer equilibrium, using sedimentation equilibrium analytical ultracentrif-
ugation. Using a similar approach, the work presented here indicates that trimeric
interactions also occur between the fusion protein TMDs of Ebola virus, influenza vi-
rus, severe acute respiratory syndrome coronavirus (SARS CoV), and rabies virus. Our
results suggest that TM-TM interactions are important in the fusion protein function
of diverse viral families.
IMPORTANCE Many important human pathogens are enveloped viruses that utilize
membrane-bound glycoproteins to mediate viral entry. Factors that contribute to
the stability of these glycoproteins have been identified in the ectodomain of sev-
eral viral fusion proteins, including residues within the soluble ectodomain. Although
it is often thought to simply act as an anchor, the transmembrane domain of viral
fusion proteins has been implicated in protein stability and function as well. Here,
using a biophysical approach, we demonstrated that the fusion protein transmem-
brane domains of several deadly pathogens—Ebola virus, influenza virus, SARS CoV,
and rabies virus—self-associate. This observation across various viral families sug-
gests that transmembrane domain interactions may be broadly relevant and serve as
a new target for therapeutic development.
KEYWORDS SARS, Ebola virus, fusion protein, influenza, rabies, transmembrane
domain, virus
Membrane fusion is a critical event in the life cycle of enveloped viruses. Fusion ofthe viral envelope with the target cell membrane is mediated by the viral fusion
protein. The trimeric fusion protein undergoes a dramatic structural rearrangement
from its metastable prefusion conformation to the postfusion conformation after
triggering by an event like receptor binding or a pH change. Factors that contribute to
prefusion stability have been identified in the ectodomain of several fusion proteins,
including residues within the stalk domain (1–4). Though often thought to act as just
an anchor, the fusion protein transmembrane domain (TMD) has been implicated in
protein stability and function. The influenza virus fusion protein, hemagglutinin (HA),
was engineered to replace the TMD with a lipid anchor, glycosyl-phosphatidylinositol
(GPI), to elucidate the role of the TMD. The GPI-HA protein was unable to efficiently
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The fusion protein transmembrane
domains of Ebola, influenza, SARS, and rabies
viruses associate as trimers, implicating
transmembrane domain interactions as
important for fusion protein function across
viral families.
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promote fusion, and the TMD was shown to be essential for pore enlargement,
implicating the TMD in protein function (5, 6). Additional studies demonstrated that
specific HA TMD residues are important for the protein’s oligomeric state and function
(7–9). Furthermore, prefusion crystal structures of parainfluenza virus 5 (PIV5) fusion
protein (F), HIV gp41, and Hendra virus (HeV) F required the addition of a trimeric
coiled-coil for prefusion stabilization, essentially acting to replace the TMD (10–12). This
requirement across viral families suggests that TM-TM interactions are broadly relevant.
Previously, we demonstrated that paramyxovirus class I fusion protein TMDs, in-
cluding those of PIV5 and HeV, self-associate in a monomer-trimer equilibrium in
isolation, as determined via sedimentation equilibrium analytical ultracentrifugation
(SE-AUC) (13). To determine whether TMD interactions are important beyond para-
myxoviruses, fusion proteins from different viral families were analyzed. The viruses
represent several major human pathogens, including Ebola virus, influenza virus, severe
acute respiratory syndrome coronavirus (SARS CoV), and rabies virus. The Ebola virus
fusion protein (GP), influenza virus HA, and SARS CoV spike protein (S) are class I viral
fusion proteins. These proteins undergo a dramatic, irreversible structural rearrange-
ment, so it is important to have mechanisms to maintain the prefusion conformation.
Unlike class I fusion proteins, some class III fusion proteins, including rabies virus GP,
can reverse the refolding process (14). Mutagenesis studies with SARS CoV S, Ebola virus
GP, and influenza virus HA implicate the TMD in proper protein folding and function;
however, none of the currently available crystal structures includes the TMD (5, 7, 15,
16). Utilizing the previously established SE-AUC system, chimeric proteins containing
the TMD of interest fused with the protein staphylococcal nuclease (SN) were analyzed
for oligomerization (Fig. 1A) (13, 17). The SN-TMD chimeric proteins were expressed in
Escherichia coli, purified into detergent micelles, and density matched using deuterated
water to negate any contribution to sedimentation by the micelle itself. It has been
shown previously that the SN protein does not oligomerize (18). As a result of this
preparation, any changes in sedimentation, as measured by absorbance, were the result
of protein oligomerization (Fig. 1B).
To determine the best model, the data points were fit to multiple models varying
from monomer to multispecies fits, such as monomer-trimer-hexamer. Residual plot-
ting and 2 and R values were used to choose the best fit, and when more than one
model was consistent with the data, the simplest model was chosen (Fig. 1C; see Fig. S1
in the supplemental material). Single-species analysis of each construct at pH 7 or 5
indicated a predicated molecular weight (N) that was greater than the molecular
weight of the monomeric species (Fig. 1C). This suggests that the SN-TM proteins are
of a higher oligomeric state or that multiple oligomeric species are present. The curve
fit for each at 20,000 rpm is shown with the residuals plotted above (Fig. 2). Although
influenza HA and rabies GP are fusion proteins of different classes (class I and class III,
respectively), both best fit a monomer-trimer model, as the addition of a hexameric
species did not improve residual distribution (Fig. 2B and D). The Ebola virus GP and
SARS CoV S SN-TMDs were determined to best fit a monomer-trimer-hexamer model at
pH 7. When the residuals for the monomer (Fig. 2, black circles) were plotted, the data
points did not fit appropriately, unlike the 3-species model, which has evenly distrib-
uted residuals (Fig. 1C and 2). The presence of an additional oligomeric species not
found for the other class I fusion proteins may be the result of association between
SN-TMD trimers.
Low pH has been described as a trigger for many viral fusion proteins, including
influenza virus HA and rabies virus GP. The rabies virus GP was found to require
exposure to pH below 6.2 to drive membrane fusion, while influenza virus HA triggers
in the acidic environment of an endosome (pH 6.0 to 6.5 in early endosomes and 4.5
to 5.5 in late endosomes) (19, 20). Though it has been shown that Ebola virus GP and
SARS CoV S proteins require low pH for function, evidence suggests that this may be
important for the cathepsin cleavage activity necessary to activate the fusion protein
but not for their conformational changes (21–23). To determine whether association
was affected by low pH, the SN-TMDs were prepared at pH 5 and analyzed via SE-AUC.
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The data points were fit to a monomer–n-mer curve (Fig. 1C) and then to multiple
species curves. The SN-TMDs for the Ebola virus GP, influenza virus HA, and SARS CoV
S at pH 5 best fit to a monomer-trimer-hexamer equilibrium, as determined by residual
plotting, 2, and R values (Fig. 2E; Fig. S2). Interestingly, the influenza virus HA SN-TMD
FIG 1 Parameters for SE-AUC. (A) Chimeric proteins were designed for SE-AUC, in which the TMD of interest was fused with the protein staphylococcal nuclease
(SN). The addition of SN aids in purification and increases the extinction coefficient, which aids data collection in absorbance-based assays. (B) SE-AUC is based
on the premise that, upon centrifugation, the species present will eventually reach an equilibrium wherein species of higher mass (such as a higher oligomeric
state) will sediment, while species of lower mass will diffuse. The resulting spectra represent an equilibrium in which higher-molecular-weight species have a
higher absorbance. The absorbance data can be fit using the following equation: Ar species n expnr2  r02 , where A represents the total absorbance
of the solution at radial position (r), while m,0 and m/t,0 represent the monomer (m) and monomer/trimer (m/t) absorbance, respectively, as the reference
radius, r0. The molecular mass (Mm) and partial specific volume (v) of the monomer in solution were estimated using SEDNTERP (http://www.rasmb.org/
sednterp/). The molecular mass for a monomer or trimer (Md/t) is a multiple of Mm. R is the universal gas constant; T is the absolute temperature; 	 is the solvent
density; 
 is the angular velocity; and  is the baseline offset. With the known molecular weight of the single species, the oligomeric state can be determined.
The program KaleidaGraph was used to fit these equations to the data. (C) Table includes the viral fusion protein, its family, and 2 and R values for the curve
fits shown in Fig. 2 at both pH 7 and 5. The single-species molecular weight (MW) is indicated for each SN-TM construct, and the best fit is indicated by an
asterisk.
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FIG 2 Trimeric association of TMDs of Ebola virus GP, SARS CoV S, rabies virus GP, and influenza virus HA, as determined by SE-AUC. Representative absorbance
spectra for each SN-TMD are shown from analysis at 20,000 rpm. Absorbance data are plotted against normalized radial position and analyzed to determine
best fit using 2 and R values and residual plotting. Analysis is shown for the monomer-trimer (1:3) (blue) and monomer-trimer-hexamer (1:3:6) (red) curve fits.
Best fit changed from pH 7 to 5 for influenza virus HA, so both sets of data are shown. Residuals are plotted above the absorbance spectra. The residuals for
the monomeric fit are also shown in black. The monomeric curve fit is indicated by the black curve on each absorbance data plot. The residuals for the 1:3 (blue)
and 1:3:6 (red) fits are overlaid to demonstrate the most appropriate fit. For example, the Ebola virus GP data points fit both 1:3 and 1:3:6 models according
to the 2 and R values; however, the residual plotting makes it apparent that the 1:3:6 fit is the most appropriate.
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protein data points exhibited a monomer-trimer equilibrium at pH 7, suggesting
pH-induced changes in association. The rabies virus GP SN-TMD protein continued to
exhibit a monomer-trimer equilibrium at both pHs. These results demonstrate that the
fusion protein TMDs of various viral families self-associate, most typically as a trimer.
The hexameric species detected are likely the result of two SN-TMD trimers interacting
with one another. The Nipah virus F protein was recently found to oligomerize, forming
higher-order species up to a hexamer of trimers (24). The Nipah virus F prefusion crystal
structure revealed that six F trimers interacted in a ring structure that may contribute
to prefusion protein stability. The close proximity of the fusion proteins in this tertiary
structure could provide a platform for the interaction between trimeric TMDs. Addi-
tionally, an earlier study with influenza virus HA demonstrated that HA proteins located
outside the site of contact were also important for membrane fusion. By interfering with
the HA outsiders, membrane fusion was inhibited, suggesting a potential role for higher-
order protein oligomerization in membrane fusion (21). Interestingly, the influenza HA
SN-TMD fit a monomer-trimer equilibrium at pH 7 and then best fit a monomer-trimer-
hexamer equilibrium at pH 5. The addition of a higher-order species at the acidic pH
supports the idea that higher-order oligomerization could be important for membrane
fusion and that the TMD interactions may contribute to the oligomerization. Direct
analysis of the TMD has been limited, largely as a result of the inherent difficulty of
working with such hydrophobic domains. Other systems have been used to study TMD
dimerization, such as the TOXCAT system; however, these systems are unable to
characterize higher-order oligomeric species (25). The data here demonstrate that
trimeric TM-TM interactions occur for class I and III viral fusion proteins of different
families. More importantly, these studies provide a tool to elucidate the residues that
are critical for TM-TM association and, therefore, potentially critical for the proper
folding and function of the full-length protein.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00047-18.
FIG S1, TIF file, 0.2 MB.
FIG S2, TIF file, 0.9 MB.
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